Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 83, Issue 2, 2007, Pages 589-595

  Chen, Liaobin ^a   Wang, Hui ^b   Wang, Jun ^c   Chen, Man ^b   Shang, Liang ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Controlled release; Ofloxacin; Osteomyelitis; Polyanhydride; Polylactide

Indexed keywords

BIODEGRADABLE POLYMERS; BONE; CELL CULTURE; PATIENT TREATMENT;

OFLOXACIN; OSTEOMYELITIS; POLYANHYDRIDE; POLYLACTIDE;

CONTROLLED DRUG DELIVERY;

OFLOXACIN; POLYANHYDRIDE; POLYLACTIDE; TETRAHYDROFURAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; BONE INFECTION; BONE RADIOGRAPHY; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; ESCHERICHIA COLI; INFECTION PREVENTION; NONHUMAN; PSEUDOMONAS AERUGINOSA; RABBIT; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; ESCHERICHIA COLI; OFLOXACIN; OSTEOMYELITIS; POLYANHYDRIDES; POLYESTERS; PSEUDOMONAS AERUGINOSA; RABBITS; STAPHYLOCOCCUS AUREUS;

EID: 35548977174     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30832     Document Type: Article

References (25)

1. Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamycin from polymethylmethacrylate beads. J Bone Joint Surg Br 1978;60B:270-275.
2. Klemm K. Gentamycin-PMMA-Beads in treating bone and soft tissue infection. Excerpta Med Orthop 1980;25:182-184.
3. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier system for the local delivery of antibiotics in bone infections. Drugs 2000;59:1223-1232.
4. Park ES, Maniar M, Shah JC. Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery. Preparation, and kinetics and mechanism of in vitro release. J Controlled Release 1998;52:179-189.
5. Jain JP, Modi S, Domb AJ, Kumar N. Role of polyanhydrides as localized drug carriers. J Controlled Release 2005;103:541-563.
6. Shieh L, Tamada J, Chen I, Pang J, Domb A, Langer R. Erosion of a new family of biodegradable polyanhydrides. J Biomed Mater Res 1994;28:1465-1475.
7. Nelson CL, Hickmon SG, Skinner RA. Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable polyanhydride-gentamicin beads. J Orthop Res 1997;15:249-255.
8. Li LC, Deng J, Stephens D. Polyanhydride implant for antibiotic delivery-from the bench to the clinic. Adv Drug Delivery Rev 2002;54:963-986.
9. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003;5:1-16.
10. Leong KW, Brott BC, Langer R. Bioerodible polyanhydrides as drug -carrier matrices. I. Characterization, degradation and release characteristics. J Biomed Mater Res 1985;19:941-955.
11. Wang H, Liao ZX, Chen M, Hu XL. Effects of hepatic fibrosis on ofloxacin pharmacokinetics and bioavailability in rats. Pharmacol Res 2006;53:28-34.
12. Henry FC. Sulfonamides, trimethoprim and quinolones. In: Katzung BG, editor. Basic and Clinical Pharmacology, 8th ed. Beijing: People's Medical Publishing House; 2001. pp 793-802.
13. Domb AJ, Rock M, Schwartz J, Perkin C, Yipchuk G, Broxup B, Villemure JG. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain. Biomaterials 1994;15:681-688.
14. Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R. Polyanhydride administration in high doses in vivo: Studies of biocompatibility and toxicology. J Biomed Mater Res 1990;24:1463-1481.
15. Andreopoulos AG, Korakis T, Dounis E, Anastasiadis A, Tzivelekis P, Kanellakopoulou K. In vitro release of new quinolones from biodegradable systems: A comparative study. J Biomater Appl 1996;10:338-347.
16. Aimin C, Chunlin H, Juliang B, Tinyin Z, Zhichao D. Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis. Clin Orthop 1999;366:239-247.
17. Yaylaoglu MB, Korkusuz P, Ors U, Korkusuz F, Hasirci V. Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release. Biomaterials 1999;20:711-719.
18. Itokazu M, Yamamoto K, Yang WY, Aoki T, Kato N, Watanabe K. The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis. Infection 1997;25:359-363.
19. Gerhart TN, Roux RD, Hanff PA, Horowitz GL, Renshaw AA, Hayes WC. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats. J Orthop Res 1993;11:250-255.
20. Sasaki S, Ishii Y. Apatite cement containing antibiotics: Efficacy in treating experimental osteomyelitis. J Orthop Sci 1999;4:361-369.
21. Arcos D, Ragel CV, Vallet-Regi M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials 2001;22:701-708.
22. Kawanabe K, Okada Y, Matsusue Y, Iida H, Nakamura T. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg Br 1998;80-B:527-530.
23. Li XD, Hu YY. The treatment of osteomyelitis with gentamycin- reconstituted bone xenograft-composite. J Bone Joint Surg Br 2001;83-B:1063-1068.
24. Wang JZ. Quinolones. In: Xie B, Wang JZ, Wu SF, editors. Practical Handbook of New Drugs, 2nd ed. Beijing: People's Medical Publishing House; 2002. pp 166-168.
25. Richard H. Quinolones and urinary tract antiseptics. In: Mycek MJ, Harvey RA, Champe PC, editors. Lippincott's Illustrated Reviews Pharmacology, 2nd ed. Beijing: Lippincott Williams & Wilkins and Peking Union Medical College Press; 2002. pp 323-330.